ACS Omega · 2023 · 24 citations · 32 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyAntibacterial AgentsAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial ResistanceAntibacterial TherapyEnzyme InhibitionMolecular Drug Susceptibility TestingPhenotypic Drug Susceptibility TestingTuberculosis Drug Development
High Resolution Image Download MS PowerPoint Slide In pursuit of new antitubercular agents, we here report the antimycobacterial (H 37 Rv) and DNA gyrase inhibitory potential of daidzein and khellin natural products (NPs). We procured a total of 16 NPs based on their pharmacophoric similarities with known antimycobacterial compounds. The H 37 Rv strain of M. tuberculosis was found to be susceptible to only two out of the 16 NPs procured; specifically, daidzein and khellin each exhibited an MIC of 25 μg/mL. Moreover, daidzein and khellin inhibited the DNA gyrase enzyme with IC 50 values of 0.042 and 0.822 μg/mL, respectively, compared to ciprofloxacin with an IC 50 value of 0.018 μg/mL. Daidzein and khellin were found to have lower toxicity toward the vero cell line, with IC 50 values of 160.81 and 300.23 μg/mL, respectively. Further, molecular docking study and MD simulation of daidzein indicated that it remained stable inside the cavity of DNA GyrB domain for 100 ns.
32
Alexandra Aubry, Xiao-Su Pan, L. Mark Fisher et al. · Antimicrobial Agents and Chemotherapy · 2004 · 234 citations · Full text
Rafat Zrieq, Iqrar Ahmad, Mejdi Snoussi et al. · International Journal of Molecular Sciences · 2021 · 102 citations · Full text